{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T16:49:54Z","timestamp":1762102194094,"version":"3.37.3"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,5,9]],"date-time":"2018-05-09T00:00:00Z","timestamp":1525824000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Ministry of Health & Welfare, Republic of Korea","award":["HI16C0628"],"award-info":[{"award-number":["HI16C0628"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Genomics"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12920-018-0361-y","type":"journal-article","created":{"date-parts":[[2018,5,8]],"date-time":"2018-05-08T23:53:53Z","timestamp":1525823633000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Integrative analyses of genes and microRNA expressions in human trisomy 21 placentas"],"prefix":"10.1186","volume":"11","author":[{"given":"Ji Hyae","family":"Lim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"You Jung","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyun Jin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moon Young","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"So Yeon","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Youl-Hee","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0710-2582","authenticated-orcid":false,"given":"Hyun Mee","family":"Ryu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,5,9]]},"reference":[{"key":"361_CR1","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1097\/GIM.0b013e3181b2e34c","volume":"11","author":"A M\u00e9garban\u00e9","year":"2009","unstructured":"M\u00e9garban\u00e9 A, Ravel A, Mircher C, Sturtz F, Grattau Y, Rethor\u00e9 MO, Delabar JM, Mobley WC. The 50th anniversary of the discovery of trisomy 21: the past, present, and future of research and treatment of trisomy 21. Genet Med. 2009;11:611\u20136.","journal-title":"Genet Med"},{"key":"361_CR2","first-page":"236","volume":"47","author":"JR Korenberg","year":"1990","unstructured":"Korenberg JR, Kawashima H, Pulst SM, Ikeuchi T, Ogasawara N, Yamamoto K, Schonberg SA, West R, Allen L, Magenis E, et al. Molecular definition of a region of chromosome 21 that causes features of the Down syndrome phenotype. Am J Hum Genet. 1990;47:236\u201346.","journal-title":"Am J Hum Genet"},{"key":"361_CR3","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/1471-2350-7-24","volume":"7","author":"CM Li","year":"2006","unstructured":"Li CM, Guo M, Salas M, Schupf N, Silverman W, Zigman WB, Husain S, Warburton D, Thaker H, Tycko B. Cell type-specific over-expression of chromosome 21 genes in fibroblasts and fetal hearts with trisomy 21. BMC Med Genet. 2006;7:24.","journal-title":"BMC Med Genet"},{"key":"361_CR4","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1046\/j.1529-8817.2003.00123.x","volume":"68","author":"S Giannone","year":"2004","unstructured":"Giannone S, Strippoli P, Vitale L, Casadei R, Canaider S, Lenzi L, D'Addabbo P, Frabetti F, Facchin F, Farina A, Carinci P, Zannotti M. Gene expression profile analysis in human T lymphocytes from patients with Down syndrome. Ann Hum Genet. 2004;68:546\u201354.","journal-title":"Ann Hum Genet"},{"key":"361_CR5","doi-asserted-by":"publisher","first-page":"R107","DOI":"10.1186\/gb-2005-6-13-r107","volume":"6","author":"R Mao","year":"2005","unstructured":"Mao R, Wang X, Spitznagel EL Jr, Frelin LP, Ting JC, Ding H, Kim JW, Ruczinski I, Downey TJ, Pevsner J. Primary and secondary transcriptional effects in the developing human Down syndrome brain and heart. Genome Biol. 2005;6:R107.","journal-title":"Genome Biol"},{"key":"361_CR6","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1146\/annurev.cellbio.23.090506.123406","volume":"23","author":"N Bushati","year":"2007","unstructured":"Bushati N, Cohen SM. microRNA functions. Annu Rev Cell Dev Biol. 2007;23:175\u2013205.","journal-title":"Annu Rev Cell Dev Biol"},{"key":"361_CR7","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.devcel.2006.09.009","volume":"11","author":"WP Kloosterman","year":"2006","unstructured":"Kloosterman WP, Plasterk RH. The diverse functions of microRNAs in animal development and disease. Dev Cell. 2006;11:441\u201350.","journal-title":"Dev Cell"},{"key":"361_CR8","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","volume":"116","author":"BDP MicroRNAs","year":"2004","unstructured":"MicroRNAs BDP. Genomics, biogenesis, mechanism, and function. Cell. 2004;116:281\u201397.","journal-title":"Cell"},{"key":"361_CR9","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1101\/gad.1399806","volume":"20","author":"MA Valencia-Sanchez","year":"2006","unstructured":"Valencia-Sanchez MA, Liu J, Hannon GJ, Parker R. Control of translation and mRNA degradation by miRNAs and siRNAs. Genes Dev. 2006;20:515\u201324.","journal-title":"Genes Dev"},{"key":"361_CR10","doi-asserted-by":"crossref","unstructured":"Friedman RC, Farh KK, Burge CB, Bartel DP. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res. 2009, 19:92\u2013105.","DOI":"10.1101\/gr.082701.108"},{"issue":"Database issue","key":"361_CR11","doi-asserted-by":"publisher","first-page":"D68","DOI":"10.1093\/nar\/gkt1181","volume":"42","author":"A Kozomara","year":"2014","unstructured":"Kozomara A, Griffiths-Jones S. miRBase: annotating high confidence microRNAs using deep sequencing data. Nucleic Acids Res. 2014;42(Database issue):D68\u201373.","journal-title":"Nucleic Acids Res"},{"key":"361_CR12","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.tcb.2006.12.007","volume":"17","author":"RS Pillai","year":"2007","unstructured":"Pillai RS, Bhattacharyya SN, Filipowicz W. Repression of protein synthesis by miRNAs: how many mechanisms? Trends Cell Biol. 2007;17:118\u201326.","journal-title":"Trends Cell Biol"},{"key":"361_CR13","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.cmet.2006.05.009","volume":"4","author":"J Kr\u00fctzfeldt","year":"2006","unstructured":"Kr\u00fctzfeldt J, Stoffel M. MicroRNAs: a new class of regulatory genes affecting metabolism. Cell Metab. 2006;4:9\u201312.","journal-title":"Cell Metab"},{"key":"361_CR14","doi-asserted-by":"publisher","first-page":"R762","DOI":"10.1016\/j.cub.2014.06.043","volume":"24","author":"BD Adams","year":"2014","unstructured":"Adams BD, Kasinski AL, Slack FJ. Aberrant regulation and function of microRNAs in cancer. Curr Biol. 2014;24:R762\u201376.","journal-title":"Curr Biol"},{"key":"361_CR15","doi-asserted-by":"publisher","first-page":"2177","DOI":"10.1016\/j.jacc.2014.01.050","volume":"63","author":"G Condorelli","year":"2014","unstructured":"Condorelli G, Latronico MV, Cavarretta E. microRNAs in cardiovascular diseases: current knowledge and the road ahead. J Am Coll Cardiol. 2014;63:2177\u201387.","journal-title":"J Am Coll Cardiol"},{"key":"361_CR16","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1111\/j.1399-0004.2008.01134.x","volume":"75","author":"KE Szulwach","year":"2009","unstructured":"Szulwach KE, Jin P, Alisch RS. Noncoding RNAs in mental retardation. Clin Genet. 2009;75:209\u201319.","journal-title":"Clin Genet"},{"issue":"7","key":"361_CR17","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1016\/j.placenta.2013.04.009","volume":"34","author":"L Huang","year":"2013","unstructured":"Huang L, Shen Z, Xu Q, Huang X, Chen Q, Li D. Increased levels of microRNA-424 are associated with the pathogenesis of fetal growth restriction. Placenta. 2013;34(7):624.","journal-title":"Placenta"},{"key":"361_CR18","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.brainres.2010.03.069","volume":"1338","author":"P Provost","year":"2010","unstructured":"Provost P. MicroRNAs as a molecular basis for mental retardation, Alzheimer's and prion diseases. Brain Res. 2010;1338:58\u201366.","journal-title":"Brain Res"},{"key":"361_CR19","doi-asserted-by":"publisher","first-page":"41","DOI":"10.3389\/fncel.2013.00041","volume":"7","author":"WH Siew","year":"2013","unstructured":"Siew WH, Tan KL, Babaei MA, Cheah PS, Ling KH. MicroRNAs and intellectual disability (ID) in Down syndrome, X-linked ID, and fragile X syndrome. Front Cell Neurosci. 2013;7:41.","journal-title":"Front Cell Neurosci"},{"key":"361_CR20","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.placenta.2014.12.020","volume":"36","author":"JH Lim","year":"2015","unstructured":"Lim JH, Kim DJ, Lee DE, Han JY, Chung JH, Ahn HK, Lee SW, Lim DH, Lee YS, Park SY, Ryu HM. Genome-wide microRNA expression profiling in placentas of fetuses with Down syndrome. Placenta. 2015;36:322\u20138.","journal-title":"Placenta"},{"key":"361_CR21","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1186\/s12864-017-3993-y","volume":"18","author":"JH Lim","year":"2017","unstructured":"Lim JH, Han YJ, Kim HJ, Kwak DW, Park SY, Chun SH, Ryu HM. Genome-wide gene expression analysis in the placenta from fetus with trisomy 21. BMC Genomics. 2017;18:720.","journal-title":"BMC Genomics"},{"key":"361_CR22","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Statist Soc B. 1995;57:289\u2013300.","journal-title":"J R Statist Soc B"},{"key":"361_CR23","doi-asserted-by":"publisher","first-page":"4997","DOI":"10.1073\/pnas.91.11.4997","volume":"91","author":"JR Korenberg","year":"1994","unstructured":"Korenberg JR, Chen XN, Schipper R, Sun Z, Gonsky R, Gerwehr S, Carpenter N, Daumer C, Dignan P, Disteche C, et al. Down syndrome phenotypes: the consequences of chromosomal imbalance. Proc Natl Acad Sci US A. 1994;91:4997\u20135001.","journal-title":"Proc Natl Acad Sci US A"},{"key":"361_CR24","first-page":"293","volume":"57","author":"MA Pritchard","year":"1999","unstructured":"Pritchard MA, Kola I. The \u201cgene dosage effect\u201d hypothesis versus the \u201camplified developmental instability\u201d hypothesis in Down syndrome. J Neural Transm Suppl. 1999;57:293\u2013303.","journal-title":"J Neural Transm Suppl"},{"key":"361_CR25","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.tig.2005.02.012","volume":"21","author":"DR FitzPatrick","year":"2005","unstructured":"FitzPatrick DR. Transcriptional consequences of autosomal trisomy: primary gene dosage with complex downstream effects. Trends Genet. 2005;21:249\u201353.","journal-title":"Trends Genet"},{"key":"361_CR26","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/j.ygeno.2007.08.005","volume":"90","author":"HE Lockstone","year":"2007","unstructured":"Lockstone HE, Harris LW, Swatton JE, Wayland MT, Holland AJ, Bahn S. Gene expression profiling in the adult Down syndrome brain. Genomics. 2007;90:647\u201360.","journal-title":"Genomics"},{"key":"361_CR27","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/nrg2290","volume":"9","author":"W Filipowicz","year":"2008","unstructured":"Filipowicz W, Bhattacharyya SN, Sonenberg N. Mechanisms of posttranscriptional regulation by microRNAs: are the answers in sight? Nat Rev Genet. 2008;9:102\u201314.","journal-title":"Nat Rev Genet"},{"key":"361_CR28","doi-asserted-by":"publisher","first-page":"4645","DOI":"10.1242\/dev.02070","volume":"132","author":"T Du","year":"2005","unstructured":"Du T, Zamore PD. microPrimer: the biogenesis and function of microRNA. Development. 2005;132:4645\u201352.","journal-title":"Development"},{"key":"361_CR29","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1186\/gb-2010-11-6-213","volume":"11","author":"JB Berletch","year":"2010","unstructured":"Berletch JB, Yang F, Disteche CM. Escape from X inactivation in mice and humans. Genome Biol. 2010;11:213.","journal-title":"Genome Biol"},{"key":"361_CR30","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1038\/ng.338","volume":"41","author":"R Song","year":"2009","unstructured":"Song R, Ro S, Michaels JD, Park C, McCarrey JR, Yan W. Many X-linked microRNAs escape meiotic sex chromosome inactivation. Nat Genet. 2009;41:488\u201393.","journal-title":"Nat Genet"},{"key":"361_CR31","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/B978-0-444-54299-1.00003-0","volume":"197","author":"B Bardoni","year":"2012","unstructured":"Bardoni B, Abekhoukh S, Zongaro S, Melko M. Intellectual disabilities, neuronal posttranscriptional RNA metabolism, and RNA-binding proteins: three actors for a complex scenario. Prog Brain Res. 2012;197:29\u201351.","journal-title":"Prog Brain Res"},{"key":"361_CR32","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/nrn2967","volume":"12","author":"LM Ittner","year":"2011","unstructured":"Ittner LM, G\u00f6tz J. Amyloid-\u03b2 and tau--a toxic pas de deux in Alzheimer's disease. Nat Rev Neurosci. 2011;12:65\u201372.","journal-title":"Nat Rev Neurosci"},{"key":"361_CR33","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1097\/NEN.0b013e318202bfa1","volume":"70","author":"J Wegiel","year":"2011","unstructured":"Wegiel J, Kaczmarski W, Barua M, Kuchna I, Nowicki K, Wang KC, Wegiel J, Yang SM, Frackowiak J, Mazur-Kolecka B, Silverman WP, Reisberg B, Monteiro I, de Leon M, Wisniewski T, Dalton A, Lai F, Hwang YW, Adayev T, Liu F, Iqbal K, Iqbal IG, Gong CX. Link between DYRK1A overexpression and several-fold enhancement of neurofibrillary degeneration with 3-repeat tau protein Down syndrome. J Neuropathol Exp Neurol. 2011;70:36\u201350.","journal-title":"J Neuropathol Exp Neurol"},{"key":"361_CR34","doi-asserted-by":"publisher","first-page":"4474","DOI":"10.1021\/jm200464w","volume":"54","author":"F Giraud","year":"2011","unstructured":"Giraud F, Alves G, Debiton E, Nauton L, Th\u00e9ry V, Durieu E, Ferandin Y, Lozach O, Meijer L, Anizon F, Pereira E, Moreau P. Synthesis, protein kinase inhibitory potencies, and in vitro antiproliferative activities of meridianin derivatives. J Med Chem. 2011;54:4474\u201389.","journal-title":"J Med Chem"},{"key":"361_CR35","unstructured":"Rosenthal AS, Tanega C, Shen M, Mott BT, Bougie JM, Nguyen DT, Misteli T, Auld DS, Maloney DJ, Thomas CJ. An inhibitor of the Cdc2-like kinase 4 (Clk4). In: Probe reports from the NIH molecular libraries program [internet]. Bethesda (MD): National Center for biotechnology information (US); 2010\u2013.2010 mar 29 [updated 2011 Mar 3]."},{"key":"361_CR36","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.neures.2009.12.003","volume":"66","author":"K Kumakura","year":"2010","unstructured":"Kumakura K, Nomura H, Toyoda T, Hashikawa K, Noguchi T, Takeda K, Ichijo H, Tsunoda M, Funatsu T, Ikegami D, Narita M, Suzuki T, Matsuki N. Hyperactivity in novelenvironment with increased dopamine and impaired noveltypreference in apoptosis signal-regulating kinase 1 (ASK1)-deficient mice. Neurosci Res. 2010;66:313\u201320.","journal-title":"Neurosci Res"},{"key":"361_CR37","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1038\/mp.2011.163","volume":"17","author":"LS Nguyen","year":"2012","unstructured":"Nguyen LS, Jolly L, Shoubridge C, Chan WK, Huang L, Laumonnier F, Raynaud M, Hackett A, Field M, Rodriguez J, Srivastava AK, Lee Y, Long R, Addington AM, Rapoport JL, Suren S, Hahn CN, Gamble J, Wilkinson MF, Corbett MA, Gecz J. Transcriptome profiling of UPF3B\/NMD-deficient lymphoblastoid cells from patients with various forms of intellectual disability. Mol Psychiatry. 2012;17:1103\u201315.","journal-title":"Mol Psychiatry"}],"container-title":["BMC Medical Genomics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12920-018-0361-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12920-018-0361-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12920-018-0361-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,6]],"date-time":"2024-07-06T16:31:22Z","timestamp":1720283482000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedgenomics.biomedcentral.com\/articles\/10.1186\/s12920-018-0361-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,9]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["361"],"URL":"https:\/\/doi.org\/10.1186\/s12920-018-0361-y","relation":{},"ISSN":["1755-8794"],"issn-type":[{"type":"electronic","value":"1755-8794"}],"subject":[],"published":{"date-parts":[[2018,5,9]]},"assertion":[{"value":"9 August 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 April 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved in accordance to the requirements of the Ethics Committee at Cheil General Hospital (#CGH-IRB-2011-85). Written informed consent was obtained from all participants in compliance with the Declaration of Helsinki.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"46"}}